Tumor Necrosis Factor α and the Anemia of Chronic Disease: Effects of Chronic Exposure to TNF on Erythropoiesis in Vivo
The anemia of chronic disease is associated with conditions in which macrophage activation occurs. Activated marrow macrophages suppress erythropoiesis in vitro, and produce tumor necrosis factor (TNF). Therefore we tested the effects of chronic in vivo exposure to TNF to determine if it were a candidate for a mediator of the anemia of chronic disease. Nude mice were inoculated with CHO cells expressing the human TNF gene, or with control cells containing the transfection vector alone. The TNF mice promptly became reticulocytopenic, and after 3 weeks their corrected reticulocytes were 2.6±.7% compared to 7.3±4% in control mice. The hematocrit at 3 weeks was 28.4±1.7% in TNF mice compared to 46±8% in control mice. This anemia was also associated with low serum iron and normal iron stores and increased erythropoietin levels. The TNF mice showed an absolute monocytosis with twice the number of circulating monocytes as control mice. The TNF mice also became mildly thrombocytopenic. Marrow CFU-E and BFU-E were profoundly decreased (1.2±2xl0* vs 8.6±2xl04 CFU-E per femur, and 6.5±lxl02 vs 8.5±.2xl04 BFU-E per femur). Splenic CFU-E and BFU-E were similarly depressed. In contrast, marrow CFU-GM and CFU-GEMM were not affected. Administration of recombinant human erythropoietin to these mice failed to reverse the suppressed erythropoiesis in mice bearing TNF producing tumors. These data demonstrated that TNF preferentially inhibits erythropoiesis in vivo, and may be important in the pathogenesis of the anemia of chronic disease.
KeywordsControl Mouse Recombinant Human Erythropoietin Erythroid Progenitor Erythropoietin Level Tumor Necrosis Factor Level
Unable to display preview. Download preview PDF.
- 6.. Alexanian, R. 1972. Erythropoietin excretion of hemolytic anemia and in the hypoferremia of chronic disease. Blood 40: 946(a) (Abstr.).Google Scholar
- 17.. Roodman, G.D., A. Bird, D. Hutzler, W. Montgomery. 1987. Tumor necrosis factor-a and hematopoietic progenitors: The effects of tumor necrosis factor on the growth of erythroid progenitors CFU-E and BFU-E and the hematopoietic cell lines K562, HL60, HEL cells. Exp. Hematol. 15: 928.Google Scholar
- 18.. Murphy, M., G. Perussia, G. Trinchieri. 1988. Effects of recombinant tumor necrosis factor, lymphotoxin, and immune interferon on proliferation and differentiation of enriched hemotopoietic precursor cells. Exp. Hematol. 16: 131.Google Scholar
- 19.. Wei, H., K. Tracy, K. Manogue, N. Nguyen, Y. Fong, D. Hesse, B. Beutler, R. Solomon, A. Cerami, S. Lowry. 1987. Cachetin mediates suppressed food intake and anemia during chronic administration. Federation Proceedings 46: 5963.Google Scholar
- 23.. Birgegard G., 0. Miller, J. Caro, A. Ersler. 1982. Serum erythropoietin levels by radioimmunoassay in polycythemia. Scand. J. Haematol. 29: 161.Google Scholar
- 31.. Broxmeyer, H.E., D.E. Williams, L. Lu, S. Cooper, S.L. Anderson, G.S. Beyer, R. Hoffman, B.Y. Rubin. 1986. The suppressive influences of human tumor necrosis factor on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: Synergism of tumor necrosis factor and interferon y. J. of Immunology 136: 4487.Google Scholar
- 36.. Munker, R., P. Koeffler. 1987. In vitro action of tumor necrosis factor on myeloid leukemia cells. Blood 69: 1102.Google Scholar
- 37.. Teppo, A.M., C.P.J. Maury. 1987. Radioimmunoassay of tumor necrosis factor in serum. Clin. Chem. 33: 2024.Google Scholar
- 39.. Feldman, L., CM. Cohen, N. Dainiak. 1986. In vitro release of physically separable factors from monocytes that exert opposing effects on erythropoiesis. Blood 67: 1454.Google Scholar